Senior Medical Science Liaison - Field-Based, KOL Leadership

Eisai, Inc.; Nevada (IA); On-site; USD 144,000 - 217,000; Full time

Job summary

Eisai Inc. seeks a Medical Science Liaison (MSL) or Senior MSL to provide scientific leadership in Oncology/Hematology across the field, engaging with healthcare providers, investigators, and KOLs to share data and advance Eisai's research.

This field-based role requires a terminal Doctorate and 3+ years in MSL for Sr., with travel up to 60% and a home-based office setup. Salary ranges listed, competitive benefits, and opportunities to influence clinical strategy.

Qualifications

• Requires an advanced, terminal Doctorate level (D-level) degree in medical or health sciences (e.g. MD, PhD, PharmD, DPH, EdD).
• Strong broad-based scientific and pharmaceutical knowledge.
• Knowledge of treatment guidelines, clinical research processes, FDA regulations and OIG guidelines are required.

Responsibilities

• Act as primary clinical/scientific resource to HCPs in territory for information pertaining to Eisai's products.
• Convey clinical, scientific and medical information between investigators and Eisai Medical Affairs.
• Lead and mentor less experienced MSLs; supervise projects as assigned.
• Facilitate IIS reviews and advise on Investigator-Initiated Studies.
• Lead field medical efforts with professional organizations and societies.

Skills

Presentation skills

Teaching skills

Communication

Cross-functional collaboration

Strategic thinking

KOL engagement

Travel readiness

Clinical scientific knowledge

Education

Doctorate (MD/PhD/PharmD)

Job description

Eisai Inc. seeks a Medical Science Liaison (MSL) or Senior MSL to provide scientific leadership in Oncology/Hematology across the field, engaging with healthcare providers, investigators, and KOLs to share data and advance Eisai's research.

This field-based role requires a terminal Doctorate and 3+ years in MSL for Sr., with travel up to 60% and a home-based office setup. Salary ranges listed, competitive benefits, and opportunities to influence clinical strategy.